Investigation Report on China's Acarbose Market, 2018-2022

According to CRI, with improved living standards, ageing population, and increasing obesity rate, the incidence of diabetes has been climbing in China. By the end of 2017, the number of diabetic patients in China exceeded 100 million, ranking first in the world and promoting the development of the diabetes drug market.

Acarbose was developed by Bayer in 1975 and first launched in Switzerland in 1986 (trade name: Glucobay). As the first FDA-approved alpha-glycosidase inhibitor in the world, it entered China in 1994 and is now recommended as a first-line drug for type 2 diabetes. Acarbose is sold far better in China than in developed countries because it reduces glucose uptake mainly by inhibiting amylase and is more suitable for Asians who eat mainly carbohydrates.

Although Acarbose has been marketed in China for more than 20 years, China's Acarbose market is dominated by Bayer, Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. and Sichuan Luye Baoguang Pharmaceutical Co., Ltd. because it is difficult to imitate Acarbose. In recent years, the market share of Bayer's Acarbose (trade name: Glucobay) is declining in China year by year, while the market share of domestic-made counterparts is rising. In 2017, the market size of Acarbose in China was about CNY 1.09 billion. Bayer's market share was about 66.4%, showing a continued momentum of decline.

According to CRI, from 2018 to 2022, the market size will continue to grow as the number of diabetic patients increases.

Email alert

Market Insights

The global frozen processed food market will be valued at US$69.11 billion by 2021 as compared to US$57.50 billion in 2014, displaying a modest CAGR of 2.7% in terms of profit. However, the global frozen processed foods ma...

As per a study piloted by the University of California, the merchandises contrived in China are linked with substantially greater carbon dioxide emanations as compared to the similar products manufactured in another place....

The global market for smart healthcare is expected to record an inspiring 25.0% CAGR between 2016 and 2020. The massively growing acceptance of healthcare wearables amongst buyers is one of the main reasons projected to bo...

The crop protection chemicals market is likely to grow at a CAGR of 5.15% to touch US$ 70.57 billion by 2021. The market propelled by the intensifying requirement for food security for the budding population, innovation in...

Thermoplastic polyolefin (TPO) is extensively used in manufacturing industries like automotive, home appliances, footwear, medical, and building and construction. Owing to its outstanding UV-resistant and durability proper...